Publications by authors named "Liz Hardaker"

Claim this Profile
F
Feasibility and physiological relevance of designing highly potent aminopeptidase-sparing leukotriene A4 hydrolase inhibitors.
Shin Numao, Franziska Hasler, Claire Laguerre, Honnappa Srinivas, Nathalie Wack, Liz Hardaker

Sci Rep· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial.
Dave Singh, Sally Worsley, Chang-Qing Zhu, Liz Hardaker, Alison Church

BMC Pulm Med· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations.
James F Donohue, Sally Worsley, Chang-Qing Zhu, Liz Hardaker, Alison Church

Respir Med· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ion channel transient receptor potential melastatin-2 does not play a role in inflammatory mouse models of chronic obstructive pulmonary diseases.
Liz Hardaker, Parmjit Bahra, Benjamin Cochin de Billy, Mark Freeman, Natalia Kupfer

Respir Res· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis